NEW YORK (GenomeWeb News) – Genometry announced today that it has signed a multi-year deal with Janssen Pharmaceutica to generate gene-expression profiles from 250,000 compounds in Janssen's small-molecule screening library using its L1000 Expression profiling system.

The L1000 is designed to produce high-dimensional, gene-expression profiles from crude cell lysates in a 384-well plate format. The technology was developed at the Broad Institute, MIT, and the Dana-Farber Cancer Institute, and exclusively licensed by Genometry for pharmaceutical applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.